EBR Systems (EBRCZ) Income from Continuing Operations (2023 - 2026)
EBR Systems' (EBRCZ) quarterly Income from Continuing Operations came in at -$17.1 million in Q1 2026, down 61.78% year-over-year from -$44.7 million in Q1 2025, and down 348.56% quarter-over-quarter from -$3.8 million in Q4 2025.
Analysis
EBR Systems (EBRCZ) Income from Continuing Operations (2023 - 2026) Analysis & Trends
EBR Systems has disclosed Income from Continuing Operations across 4 years of filings, most recently posting -$17.1 million for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 61.78% year-over-year to -$17.1 million; the TTM figure through Mar 2026 stood at -$45.0 million (down 33.94% YoY), while the FY2025 annual figure was -$38.5 million, down 19.54% from the prior year.
- Income from Continuing Operations came in at -$17.1 million for Q1 2026 at EBR Systems, down from -$3.8 million in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of -$1.5 million in Q4 2024 to a low of -$17.1 million in Q1 2026.
- Average Income from Continuing Operations over 4 years is -$9.1 million, with a median of -$10.1 million recorded in 2024.
- Year-over-year, Income from Continuing Operations jumped 49.1% in 2024 and slumped 150.52% in 2025.
- Over 4 years, Income from Continuing Operations stood at -$3.0 million in 2023, then surged by 49.1% to -$1.5 million in 2024, then plunged by 150.52% to -$3.8 million in 2025, then tumbled by 348.56% to -$17.1 million in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were -$17.1 million in Q1 2026, -$3.8 million in Q4 2025, and -$12.2 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -92.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 201.00 Mn |
| 10 | EBR Systems | 10.83 Mn | 10.83 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -17.07 Mn |
| Dec 31, 2025 | -3.81 Mn |
| Sep 30, 2025 | -12.19 Mn |
| Jun 30, 2025 | -11.97 Mn |
| Mar 31, 2025 | -10.55 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Sep 30, 2024 | -10.06 Mn |
| Jun 30, 2024 | -11.49 Mn |
| Mar 31, 2024 | -9.15 Mn |
| Dec 31, 2023 | -2.99 Mn |
| Sep 30, 2023 | -9.13 Mn |